Clinical trial
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
NCT00014989 · The George Washington University Biostatistics Center, Other · Completed
Key facts
| NCT number | NCT00014989 |
|---|---|
| Title | Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial) |
| Official title | Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM) |
| Acronym | BEAM |
| Lead sponsor | The George Washington University Biostatistics Center, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cerebral Palsy, Intraventricular Hemorrhage, Periventricular Leukomalacia, Pulmonary Edema, Abruptio Placentae |
| Intervention type | Drug |
| Interventions | magnesium sulfate |
| Enrollment | 2,136 |
| Start date | Dec 1, 1997 |
| Primary completion | Feb 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Apr 18, 2001 |
| Last update posted | Jul 12, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: